Prospect News: News for Sterling Biotech Ltd.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with S > Issuers starting with S, CV only > All stories on Sterling Biotech Ltd. > Stories on Sterling Biotech Ltd., CV only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Sterling Biotech Ltd.

3/24/2014	CVLM	Sterling Biotech replaces all convertibles due 2012 in exchange offer
11/21/2013	CVLM	Sterling Biotech holders approve exchange, substitution of bonds
10/30/2013	CVLM	Sterling Biotech holders to vote on exchange at Nov. 20 meeting
5/30/2013	CVLM	Sterling Biotech holders authorize restructuring for convertible bonds
5/25/2012	CVDD	Sterling Biotech CDS settlement auction will not be held, ISDA says
10/4/2010	CVLM	Sterling Biotech calls in full 0.5% foreign currency convertibles
7/14/2010	CVLM	Sterling Biotech buys back, cancels $13.73 million 0.5% convertibles
6/7/2010	CV	Sterling Biotech cuts conversion price on 0% convertibles due 2012
1/12/2010	CV	Sterling Biotech buys $90.5 million in foreign-currency convertibles
3/5/2008	CV	Sterling Biotech gets shareholder OK to issue up to $250 million of convertibles
2/7/2008	CV	India's Sterling Biotech OKs up to $250 million in convertibles
4/20/2007	CV	New Issue: Sterling Biotech sells $250 million five-year zero-coupon convertibles at 6.35%, up 25%
9/8/2005	CVEM	New Issue: India's Sterling Biotech $140 million convertibles price with 0.5% coupon, up 21%
9/20/2004	CVEM	India's Sterling Biotech sells $20 million additional convertibles
9/14/2004	CVEM	New Issue: India's Sterling Biotech sells $70 million convertibles

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.